ERBB2 and colorectal adenocarcinoma: In addition to atypical BRAF mutations, ERBB2/HER2 genomic alterations are also different when comparing duodenal SBAs to jejunal/ileal SBAs, and when comparing SBAs to gastric and colorectal adenocarcinomas (Figure 1B).